US regulators relax restrictions on rosiglitazone.
作者信息
McCarthy Michael
机构信息
Seattle.
出版信息
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
PMID:24286989
Abstract
摘要
相似文献
1
US regulators relax restrictions on rosiglitazone.美国监管机构放宽对罗格列酮的限制。
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
2
Rosiglitazone, medical reversal, and back to basics for diabetes.罗格列酮、医学逆转与糖尿病回归基础
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
3
FDA panel advises easing restrictions on rosiglitazone.美国食品药品监督管理局专家小组建议放宽对罗格列酮的限制。
BMJ. 2013 Jun 10;346:f3769. doi: 10.1136/bmj.f3769.
4
Diabetes drug safety update: Avandia and your heart.糖尿病药物安全性更新：文迪雅与您的心脏
Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7.
5
The rosiglitazone story--lessons from an FDA Advisory Committee meeting.罗格列酮事件——美国食品药品监督管理局咨询委员会会议的教训
N Engl J Med. 2007 Aug 30;357(9):844-6. doi: 10.1056/NEJMp078167. Epub 2007 Aug 8.
6
Rosiglitazone and implications for pharmacovigilance.罗格列酮及其对药物警戒的意义。
BMJ. 2007 Jun 16;334(7606):1233-4. doi: 10.1136/bmj.39245.502546.BE.
7
Rosiglitazone.罗格列酮
Prim Care Diabetes. 2009 May;3(2):123-4. doi: 10.1016/j.pcd.2009.05.002. Epub 2009 May 30.
8
Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.专家组建议放宽对罗格列酮的限制，尽管存在心血管安全性方面的担忧。
JAMA. 2013 Jul 17;310(3):246-7. doi: 10.1001/jama.2013.8141.
9
[Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].[预防糖尿病患者梗死。降低血糖和糖化血红蛋白是不够的]
MMW Fortschr Med. 2003 May 8;145(19):41.
10
The long Avandia endgame.文迪雅漫长的终局。
Lancet. 2011 Jul 9;378(9786):113. doi: 10.1016/s0140-6736(11)61071-4.
引用本文的文献
1
Bayesian estimation and testing in random-effects meta-analysis of rare binary events allowing for flexible group variability.贝叶斯估计和检验在允许灵活组间变异性的罕见二项事件的随机效应荟萃分析中的应用。
Stat Med. 2023 May 20;42(11):1699-1721. doi: 10.1002/sim.9695. Epub 2023 Mar 4.
2
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.通过共享数据更新罗格列酮与心血管风险的认识：个体患者和汇总水平荟萃分析。
BMJ. 2020 Feb 5;368:l7078. doi: 10.1136/bmj.l7078.
3
Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.罗格列酮治疗可恢复充血性心力衰竭大鼠肾脏对心钠肽的反应性。
J Cell Mol Med. 2019 Jul;23(7):4779-4794. doi: 10.1111/jcmm.14366. Epub 2019 May 13.
4
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert.2007年美国食品药品监督管理局发布安全警报后罗格列酮停药情况的差异
Med Care. 2016 Apr;54(4):406-13. doi: 10.1097/MLR.0000000000000502.
5
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes.β细胞功能在2型糖尿病治疗中的重要性。
J Clin Med. 2014 Aug 14;3(3):923-43. doi: 10.3390/jcm3030923.
6
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.β 细胞功能障碍：在 2 型糖尿病的预防和管理中的关键作用。
World J Diabetes. 2015 Feb 15;6(1):109-24. doi: 10.4239/wjd.v6.i1.109.
Zotero 插件